29th Annual Meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID)

30 August – 2 September 2012
Marina Congress Center, Helsinki, Finland

 

Thursday, 30 August

12:00 – 18:00 Registration open at Marina Congress Center (2nd floor)

 

14:00 – 15:00 Satellite symposium: Fennia 2
Sponsored by Baxter, CSL Behring, Octapharma Nordic, Sanquin
Practical approach to suspicion of immunodeficiency
Chairperson: Leena Kainulainen, Finland

14:00 Suspecting immunodeficiency in a child – how to investigate? 
Anders Fasth, Sweden
14:30 Suspecting hypogammaglobulinemia in an adult – how to proceed? 
Timi Martelius, Finland

 

15:30 – 18:00 Mini course: Fennia 2
New aspects of immune response for non-immunologists
Chairpersons: Anu Kantele, Finland and Asko Järvinen, Finland

15:30 How are intruders recognized by the host? I-03
Hanna Jarva, Finland

16:00 T-cells, what, where, when? I-04
Petteri Arstila, Finland

16:30 Break

16:50 Role of complement cascade in immune defence I-05
Sakari Jokiranta, Finland

17:20 Microbes, tolerance and autoimmunity
Olli Lassila, Finland

18:30 – Mini course dinner at Restaurant Sipuli

 

Friday, 31 August

09:00 – 12:00 Interactive satellite symposium: Europaea
Sponsored by Astellas
Recurring Clostridium difficile – challenges and solutions
Chairpersons: Veli-Jukka Anttila, Finland and Jan Kristian Damås, Norway

09:00 Chairpersons’ opening remarks

09:10 Epidemiology and diagnosis of CDI
Ed Kuijpers, The Netherlands

09:40 Impact on patient and recurrences
Torbjörn Norén, Sweden

10:20 Coffee break

10:50 Existing treatment options
Magnus Gottfredsson, Iceland

11:15 New medical treatment options – what do they offer?
Oliver Cornely, Germany

11:50 Chairpersons’ closing remarks

12:00 – 13:00 Lunch / exhibition

13:00 – 13:15 Opening of the meeting, Europaea

 

13:15 – 14:45 Symposium 1: Multi-drug resistance in Enterobacteriaceae
Chairpersons: Martin Sundqvist, Sweden and Antti Hakanen, Finland

13:15 Epidemiological update I-06
Jari Jalava, Finland

13:45 Why are some MDR clones and resistance genes successful?
Christian G. Giske, Sweden

14:15 Do surveillance programs work in the control of multi-drug resistance? I-07
Antti Nissinen, Finland

14:45 – 15:30 Coffee / posters / exhibition

 

15:30 – 16:30 Free oral papers Europaea
Chairpersons: Niels Frimodt-Møller, Denmark and Antti Nissinen, Finland

A rapid flow cytometric method for distinguishing between febrile bacterial and viral infections O-1
Jari Nuutila, Finland

Detection of important resistance phenotypes using rapid disk diffusion O-2
Martin Sundqvist, Sweden

Penicillin non-susceptible pneumococci in Iceland, 1995-2010 O-3
Martha Á. Hjálmarsdóttir, Iceland

Virus etiology of the first acute wheezy episode in small children O-4
Riitta Nieminen, Finland

Clinical use of Toll-like receptor 9 agonist CpG ODN 7909 to reduce the proviral reservoir 
in HAART-treated HIV-infected patients O-5
Anni Winckelmann, Denmark

16:30 – 16:45 Break / posters / exhibition

 

16:45 – 18:00 Interactive symposium Europaea
Empirical treatment of common infections in Nordic countries
Moderators: Jukka Lumio, Finland and Harri Saxén, Finland
Chairperson: Anu Kantele, Finland

18:30 – 20:00 Helsinki city reception at Helsinki City Hall

 

Saturday, 1 September

08:30 – 10:00 Symposium 2: Current challenges and future promises in vaccination Europaea
Chairpersons: Karl G. Kristinsson, Iceland and Anu Kantele, Finland

08:30 Hyporesponsiveness – should we abandon polysaccharide vaccines? I-08
Ingileif Jónsdóttir, Iceland

09:00 Estimating rare side effects of vaccines based on population statistics I-09
Lars Østergaard, Denmark

09:30 Vaccines in immunocompromised patients I-10
Ole Søgaard, Denmar

10:00 – 10:30 Coffee / posters / exhibition

 

10:30 – 11:45 Invited young scientists Europaea
Chairpersons: Anders Johansson, Sweden and Leena Kainulainen, Finland

Selection of E.coli ST131 CTX-M-15 (E65) by common antibiotics in the mouse Y-1
intestinal colonisation model
Frederik Boëtius Hertz, Denmark

Tamiflu® – Use It and Lose It? Y-2
Josef D. Järhult, Sweden

Efficacy of Mecillinam in the empirical treatment of community acquired urinary tract Y-3
infections caused by ESBL positive and ESBL negative bacteria. Arne Søraas, Norway

Antimicrobial treatment for acute otitis media Y-4
Paula Tähtinen, Finland

A longterm nationwide observational study of invasive Group A Streptococcal infections: Y-5
Associations between clinical presentation and emm types 
Lovísa Björk Ólafsdóttir, Iceland

11:45 – 13:00 Lunch / exhibition

 

13:00 – 13:45 Honorary lecture Europaea
Chairperson: Asko Järvinen, Finland

Childhood community-acquired pneumonia
Olli Ruuskanen, Finland

13:45 – 14:00 Break / posters / exhibition

 

14:00 – 15:30 Symposium 3: Evolving laboratory diagnostics – Europaea
what does it give to clinician and patient?
Chairpersons: Arnfinn Sundsfjord, Norway and Janne-Juhana Aittoniemi, Finland

14:00 The role of rapid tests in sepsis – View of clinical microbiologist I-11
Martin Sundqvist, Sweden

14:30 The role of rapid tests in sepsis – View of infectious disease clinician I-12
Reetta Huttunen, Finland

15:00 Use of whole-genome sequencing in outbreak investigations I-13
Anders Johansson, Swede

15:30 – 16:15 Coffee / posters / exhibition

 

16:15 – 17:45 Symposium 4: Emerging and re-emerging viral diseases Europaea
Chairpersons: Lars Østergaard, Denmark and Tytti Vuorinen, Finland

16:15 Re-entry of measles
Heikki Peltola, Finland

16:45 Recent progress in antiviral therapy I-14
Tomas Bergström, Sweden

17:15 Newly found DNA viruses – diseases and diagnosis
Klaus Hedman, Finland

18:30 Bus transfers to congress dinner from Scandic Grand Marina Hotel

19:00 – Congress dinner at Restaurant Saaristo (address: Klippan, Ehrenströmintie

 

Sunday, 2 September

09:00 – 09:45 NSCMID General Assembly

09:45 – 10:00 Coffee / posters / exhibition

 

10:00 – 11:15 Symposium 5: Year in infectious diseases: Nordic perspective Europaea
Chairpersons: Christian G. Giske, Sweden and Katariina Kainulainen, Finland

10:00 Clinical microbiology
Truls Leegaard, Norway

10:18 Clinical virology
Maija Lappalainen, Finland

10:36 Clinical infectious diseases in adults
Magnus Gottfredsson, Iceland

10:54 Clinical infectious diseases in children I-15
Terho Heikkinen, Finland

11:15 – 11:45 Coffee / posters / exhibition

 

11:45 – 12:45 Pro – con symposium Europaea
Chairpersons: Karl G. Kristinsson, Iceland and Antti Nissinen, Finland
Is controlling the consumption of antimicrobial agents the key factor in reducing resistance?
Pentti Huovinen, Finland

 

12:45 – 13:15 Keynote lecture
Chairpersons: Terho Heikkinen, Finland and Janne-Juhana Aittoniemi, Finland
New treatments in chronic hepatitis C I-16
Ola Weiland, Sweden

13:15 – 13:30 Closing remarks and adjourn

13:30 Farewell lunch